Skip to main content
Premium Trial:

Request an Annual Quote

David Smoller and Melvin Booth

Premium

Sigma-Aldrich has named David Smoller vice president of research and development, the company said on June 10.

According to a company statement, Smoller will be expected to “help expand Sigma-Aldrich’s leadership position through the development of new and innovative products for life science and high technology research.”

Smoller founded Genome Systems in 1992, and remained president of the company until 1996, when it was acquired by Incyte. Smoller then joined Incyte as vice president, and eventually became senior vice president, his most recent position. As such, he managed that company’s genomics business, which boasted over $150 million in annual sales, Sigma-Aldrich said.

Smoller earned his PhD in molecular biology from Emory University, and completed postdocs at Washington University and Monsanto.


Millipore announced last week that it has elected Melvin Booth to its board of directors.

Most recently, Booth served as president and chief operating officer at MedImmune, a position from which he retired in January. He remains on MedImmune’s board, and also serves on the boards of Focus Technologies, Nova Screen BioSciences, and Prestwick Pharmaceuticals.

Prior to MedImmune, Booth was president and chief operating officer of Human Genome Sciences. He has also held various senior management positions at Syntex.

Booth has an honorary doctor of science degree from Northwest Missouri State University, and is a certified public accountant.

 

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.